Dr. Sameer Nagpal, M.D.
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- Emory University School of Medicine (2011)
- Years since graduation
- 15
- In the NPI registry since
- 2011
- Medicare patients seen, 2024
- 369
Licensed in Connecticut since 2014, according to the Connecticut Department of Public Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Medical school: Emory University School of Medicine
- 2011Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
CT license 52975 (first issued 2014; active) -
Cardiovascular Disease Physician
CT license 52975 (first issued 2014; active) -
Internal Medicine Physician
CT license 52975 (first issued 2014; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Yale-New Haven Hospital New Haven, CT
- Bridgeport Hospital Bridgeport, CT
- Greenwich Hospital Association - Greenwich, CT
Medical groups
- Yale University (2,645 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 369
- Services billed
- 940
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 162 | 113 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 132 | 118 |
| Established patient office or other outpatient visit, 30-39 minutes | 117 | 80 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 57 | 54 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 45 | 45 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 35 | 31 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 29 | 25 |
| New patient office or other outpatient visit, 30-44 minutes | 25 | 25 |
| Review by radiologist of arm or leg artery image | 23 | 22 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial second order branch | 19 | 17 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 3 payments worth $2,142 in total to this clinician.
| Veryan Medical Incorporated | $2,142 |
|---|
| Consulting Fee | $2,000 |
|---|---|
| Food and Beverage | $142 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Veryan Medical Incorporated Jun 15, 2025 | Consulting Fee BioMimics 3D Vascular Stent System · Vascular Stent | $2,000 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $13,864 in research payments for these studies, mostly to the institutions running them.
- NCT04227899--LIFE-BTK Randomized Controlled Trial
Abbott Laboratories
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.